Considerations such as those that heparanase is the product of a single gene and is upregulated in several human malignant tumors [109], in activated pro-inflammatory cells [110], and in a number of other pathological conditions [111,112], make heparanase an interesting target for drug development [113,114]. Here, HPSE is linked to cancer.